J&J MedTech Launches Cereglide 92 Catheter to Treat Acute Ischemic Stroke – Endovascular Today
February 14, 2024—Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.
February 14, 2024—Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.
Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial…
Rate-adaptive pacing (RAP) complements heart rate (HR) responses in patients with cardiac pacing devices and chronotropic incompetence, although improvements in exercise capacity have varied across…
Understanding who God is and that he loves you with an everlasting love is the foundation for a life filled with hope. But it is…
Cardiovascular care delivered by the Veterans Healthcare Administration (VHA) is equivalent or better than that provided by non-VHA community care, according to a State-of-the-Art Review…
A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…
DALLAS, Feb. 18, 2025 — Five regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people…
This study compared the prognostic value of OCT-defined TCFA and μQFR in predicting long-term outcomes of non-culprit lesions in AMI patients.
CHAMPION TROPHY PREVIEW 2025 A look back and a look aheadWelcome to The Sports Clinic Podcast where we discuss sports from around the world, both…
A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…
This case series highlights the successful application of robotic-assisted percutaneous coronary intervention using the R-One+ system in two acute coronary syndrome patients with significant coronary…